In the last trading session, 57343.0 iBio Inc (AMEX:IBIO) shares changed hands as the company’s beta touched -3.34. With the company’s per share price at $2.42 changed hands at $0.06 or 2.34% during last session, the market valuation stood at $21.32M. IBIO’s last price was a discount, traded about -105.79% off its 52-week high of $4.98. The share price had its 52-week low at $1.02, which suggests the last value was 57.85% up since then. When we look at iBio Inc’s average trading volume, we note the 10-day average is 86040.0 shares, with the 3-month average coming to 145.21K.
Analysts gave the iBio Inc (IBIO) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.00. If we narrow down to specifics, the data shows that 0 out of 3 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 1 recommended IBIO as a Hold, 2 felt it is a Buy and 0 rated the stock as Underweight. iBio Inc’s EPS for the current quarter is expected to be -0.45.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
iBio Inc (AMEX:IBIO) trade information
Instantly IBIO was in green as seen at the end of in last trading. With action -3.72%, the performance over the past five days has been red. The company’s shares are showing year-to-date upside of 70.07%, with the 5-day performance at -3.72% in the red. However, in the 30-day time frame, iBio Inc (AMEX:IBIO) is -11.74% down. Looking at the short shares, we see there were 0.2 million shares sold at short interest cover period of 1.92 days.
The consensus price target for the stock as assigned by Wall Street analysts is 3.6, meaning bulls need an upside of 32.78% from its current market value. According to analyst projections, IBIO’s forecast low is 3.6 with 3.6 as the target high. To hit the forecast high, the stock’s price needs a -48.76% plunge from its current level, while the stock would need to soar -48.76% for it to hit the projected low.
iBio Inc (IBIO) estimates and forecasts
Data shows that the iBio Inc share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot 12.56% over the past 6 months, a 56.82% in annual growth rate that is considerably higher than the industry average of 16.70%. Year-over-year growth is forecast to reach -100.00% down from the last financial year.
According to analysts, the company will likely register a growth in its current quarter sales, forecast at 0.00%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 57.55%. The 2024 estimates are for iBio Inc earnings to increase by 62.28%.
IBIO Dividends
iBio Inc is expected to release its next quarterly earnings report in January.
iBio Inc (AMEX:IBIO)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 0.14% of iBio Inc shares while 31.49% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 31.53%.
